19 terminated. 19 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 19 | Terminated 19 |
| Phase 2 | 6 | Terminated 6 |
Follow Vector Borne Diseases: new trials by email Literature Review of Vector Borne Diseases trials Research Report on Vector Borne Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia BBV87 Chikungunya vaccine, Normal Saline - Chikungunya | Phase 2 / Phase 3 | Terminated | International Vaccine Institute | 3210 | 2021-08-01 | 2025-06-22 |
| Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria artemether:lumefantrine (2.5 mg:30 mg) - Plasmodium Falciparum Malaria | Phase 2 / Phase 3 | Terminated | Novartis Pharmaceuticals | 28 | 2020-12-21 | 2026-01-13 |
| Symptomatic Management of Lyme Arthritis Naproxen, Acetaminophen - Lyme Arthritis, Lyme Disease | Phase 3 | Terminated | Desiree Neville, MD | 3 | 2019-10-01 | 2025-11-17 |
| Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan HECT-CL - Cutaneous Leishmaniases | Phase 3 | Terminated | Medecins Sans Frontieres, Netherlands | 56 | 2017-10-04 | 2019-01-16 |
| Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects CYD Dengue Vaccine, Tdap: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine adsorbed, Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed - Dengue Fever, Dengue Hemorrhagic Fever | Phase 3 | Terminated | Sanofi Pasteur, a Sanofi Company | 688 | 2016-12-19 | 2022-03-25 |
| Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient - Malaria | Phase 2 / Phase 3 | Terminated | London School of Hygiene and Tropical Medicine | 61 | 2015-12-01 | 2016-09-09 |
| The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania abamectin and fenpyroximate - Malaria | Phase 3 | Terminated | National Institute for Medical Research, Tanzania | 4917 | 2015-11-09 | 2019-02-05 |
| High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus Fluconazole, Meglumine Antimoniate - Cutaneous Leishmaniasis | Phase 3 | Terminated | Hospital Universitário Professor Edgard Santos | 53 | 2014-02-01 | 2015-12-02 |
| Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy Cotrimoxazole, Sulfadoxine-pyrimethamine - Malaria in Pregnancy | Phase 3 | Terminated | Institute of Tropical Medicine, Belgium | 352 | 2009-02-01 | 2016-01-18 |
| Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis Glucantime®, Zithromax ® - Cutaneous Leishmaniasis | Phase 2 / Phase 3 | Terminated | Ana Rabello | 48 | 2008-06-01 | 2014-10-17 |
| Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes Permethrin, Placebo - Lyme Disease | Phase 3 | Terminated | University of Minnesota | 61 | 2008-06-01 | 2020-06-04 |
| Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria Pyronaridine - artesunate, Chloroquine - Malaria | Phase 3 | Terminated | Medicines for Malaria Venture | 30 | 2007-09-06 | 2022-01-26 |
| IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria. sulphadoxine/pyrimethamine, Chlorproguanil/dapsone, Sulfadoxine/pyrimethamine - Malaria | Phase 3 | Terminated | London School of Hygiene and Tropical Medicine | 112 | 2006-07-01 | 2017-01-26 |
| CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease Chloroquine - Chikungunya Virus | Phase 3 | Terminated | Assistance Publique Hopitaux De Marseille | 2006-05-01 | 2015-08-28 | |
| Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis controlled nitric oxide releasing patch, meglumine antimoniate - Cutaneous Leishmaniasis | Phase 3 | Terminated | Fundación Cardiovascular de Colombia | 178 | 2006-05-01 | 2010-11-24 |
| Cell Therapy in Chagas Cardiomyopathy Stem cell, Filgrastime (G-CSF), Standart therapy - Chagas Cardiomyopathy | Phase 3 | Terminated | Ministry of Health, Brazil | 182 | 2006-01-01 | 2017-03-13 |
| Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia Azithromycin/Chloroquine, Sulfadoxine-Pyrimethamine/Chloroquine - Malaria, Falciparum | Phase 2 / Phase 3 | Terminated | Pfizer | 32 | 2004-03-01 | 2008-11-03 |
| Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda Eflornithine plus Nifurtimox combination therapy - Trypanosomiasis, African | Phase 2 / Phase 3 | Terminated | Epicentre | 31 | 2002-10-01 | 2007-06-21 |
| Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d, melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d, nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d - Trypanosomiasis, African | Phase 3 | Terminated | Epicentre | 435 | 2001-03-01 | 2006-05-26 |
Malaria (6) · Leishmaniasis, Cutaneous (4) · Chikungunya Fever (2) · Lyme Disease (2) · Malaria, Falciparum (2) · Trypanosomiasis, African (2) · Arthritis (1) · Cardiomyopathy, Dilated (1) · Chagas Cardiomyopathy (1) · Dengue (1) · Hyperthermia (1) · Leishmaniasis (1) · Malaria, Vivax (1) · Severe Dengue (1) · Trypanosomiasis (1)
Infections (19) · Parasitic Diseases (14) · Protozoan Infections (14) · Mosquito-Borne Diseases (10) · Euglenozoa Infections (7) · Skin Diseases (4) · Skin Diseases, Infectious (4) · Skin Diseases, Parasitic (4) · Skin and Connective Tissue Diseases (4) · Arbovirus Infections (3) · Leishmaniasis (3) · RNA Virus Infections (3) · Virus Diseases (3) · Alphavirus Infections (2)
Chloroquine (3) · Meglumine Antimoniate (3) · fanasil, pyrimethamine drug combination (3) · Azithromycin (2) · Eflornithine (2) · Acetaminophen (1) · Dengue Vaccines (1) · Fluconazole (1) · Granulocyte Colony-Stimulating Factor (1) · Melarsoprol (1) · Naproxen (1) · Nifurtimox (1) · Permethrin (1) · Saline Solution (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Epicentre (2) · London School of Hygiene and Tropical Medicine (2) · Ana Rabello (1) · Assistance Publique Hopitaux De Marseille (1) · Desiree Neville, MD (1) · Fundación Cardiovascular de Colombia (1) · Hospital Universitário Professor Edgard Santos (1) · Institute of Tropical Medicine, Belgium (1) · International Vaccine Institute (1) · Medecins Sans Frontieres, Netherlands (1) · Medicines for Malaria Venture (1) · Ministry of Health, Brazil (1) · National Institute for Medical Research, Tanzania (1) · Novartis Pharmaceuticals (1) · Pfizer (1)
Brazil (3) · Colombia (2) · Tanzania (2) · Uganda (2) · United States (2) · Burkina Faso (1) · Costa Rica (1) · Democratic Republic of the Congo (1) · France (1) · Guatemala (1) · Pakistan (1) · Panama (1) · Philippines (1) · South Korea (1) · Thailand (1)
Ana Rabello, MD PhD (1) · Christian F Rueda-Clausen, MD (1) · Christine Manyando, MD (1) · Daniel J Smith, PhD (1) · Daniel Smith, PhD (1) · David R. Boulware, MD, MPH (1) · Desiree NW Neville, MD (1) · Federico A Silva, MD (1) · Gerardo Priotto, MD MPH (1) · Gerardo Priotto, MD, MPH (1) · Gilson Feitosa, MD (1) · Hernando Mosquera, MD (1) · Isabela Ribeiro, MD (1)
PMID 19238219, PMID 22523306, PMID 24830749, PMID 27456339, PMID 27803094, PMID 29324864, PMID 34117198, PMID 34521374, PMID 39324693, PMID 41199347
2019 (1)